This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schelbert, H. R. Search for Related Content PubMed PubMed Citation Articles by Schelbert, H. R. Pubmed/NCBI databases Medline Plus Health Information Heart Attack Nuclear Scans

(Circulation. 1995;91:1894-1895.)
© 1995 American Heart Association, Inc.

Articles

Different Roads to the Assessment of Myocardial Viability

Lessons From PET for SPECT

Heinrich R. Schelbert, MD

From the Division of Nuclear Medicine, Department of Molecular and Medical Pharmacology, UCLA School of Medicine, Los Angeles, Calif.

Correspondence to Heinrich R. Schelbert, MD, Department of Molecular and Medical Pharmacology, UCLA School of Medicine, Los Angeles, CA 90095-1735.

	Introduction

 
The assessment of myocardial viability remains clinically important, yet diagnostically challenging. Tamaki et al¹ probe various approaches with positron emission tomography (PET). Since myocardial viability refers to a state of reversible impairment of contractile function, the authors correctly measure the accuracy of each approach against the postrevascularization outcome in systolic segmental wall motion as a yardstick of myocardial viability. The investigators conclude that (1) severe flow reductions accurately define myocardium as nonviable. In contrast, mild to modest reductions discriminate only poorly between viable and nonviable tissue. (2) The addition of stress-induced defects incrementally improves the identification of viable myocardium, even though the reasons for such improvement remain uncertain. (3) The combined evaluation of rest blood flow and ¹⁸F-deoxyglucose uptake as a tracer of exogenous glucose utilization distinguishes most reliably between viable and nonviable myocardium. As the authors acknowledge, the latter observation on the high predictive accuracy of blood flow metabolism patterns represents an extension of their earlier work.^{2 3} Together with other previous investigations,^{4 5 6 7} the present data further strengthen the case of flow metabolism patterns as accurate indexes of the myocardial state. Yet, the study does not answer clinically or therapeutically critical questions. It would have been important to know the effects of revascularization on global left ventricular function, clinical symptoms, or both and how such changes might relate to mismatches and their extent.^{4 8} Thus, we must rely on changes in segmental function as surrogates of changes in global function.

Although the negative predictive accuracy of the flow metabolism matches, 92%, . . . [Full Text of this Article]

This article has been cited by other articles:

				W. Y. Szeto, R. C. Gorman, J. H. Gorman III, and M. A. Acker Ischemic Mitral Regurgitation Card. Surg. Adult, January 1, 2008; 3(2008): 785 - 802. [Full Text]

				R. C. Gorman, J. H. Gorman III, and L. H. Edmunds Jr. Ischemic Mitral Regurgitation Card. Surg. Adult, January 1, 2003; 2(2003): 751 - 769. [Full Text]

				W. J. Flameng, B. Shivalkar, B. Spiessens, A. Maes, J. Nuyts, J. VanHaecke, and L. Mortelmans PET Scan Predicts Recovery of Left Ventricular Function After Coronary Artery Bypass Operation Ann. Thorac. Surg., December 1, 1997; 64(6): 1694 - 1701. [Abstract] [Full Text]

				B. Shivalkar, A. Maes, M. Borgers, J. Ausma, I. Scheys, J. Nuyts, L. Mortelmans, and W. Flameng Only Hibernating Myocardium Invariably Shows Early Recovery After Coronary Revascularization Circulation, August 1, 1996; 94(3): 308 - 315. [Abstract] [Full Text]